ScoreWhy is Godavari Drugs Ltd ?
1
Weak Long Term Fundamental Strength with a -2.98% CAGR growth in Net Sales over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.27 times
2
Flat results in Dec 25
- NET SALES(Q) Lowest at Rs 22.18 cr
- EPS(Q) Lowest at Rs 1.01
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 13-Apr-26 and has generated 32.26% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROCE of 9.1, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 28.97%, its profits have fallen by -43.4%
5
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 1.97% over the previous quarter and collectively hold 2.47% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Godavari Drugs should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Godavari Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Godavari Drugs
71.57%
0.49
59.67%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-4.90%
EBIT Growth (5y)
-4.19%
EBIT to Interest (avg)
2.25
Debt to EBITDA (avg)
3.93
Net Debt to Equity (avg)
0.88
Sales to Capital Employed (avg)
1.96
Tax Ratio
15.79%
Dividend Payout Ratio
0
Pledged Shares
0.21%
Institutional Holding
2.74%
ROCE (avg)
12.90%
ROE (avg)
11.67%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
39
Industry P/E
36
Price to Book Value
2.17
EV to EBIT
28.62
EV to EBITDA
21.66
EV to Capital Employed
1.62
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.94%
ROE (Latest)
5.52%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET SALES(Latest six months)
At Rs 61.12 cr has Grown at 23.95%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Godavari Drugs
Net Sales - Latest six months
At Rs 61.12 cr has Grown at 23.95%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
